Novo Nordisk CEO grilled by Congress over Ozempic, Wegovy prices in US WSOC TV [Video]

WASHINGTON — For the millions of people living with diabetes or obesity, drugs like Ozempic and Wegovy can significantly improve their health.

But the out-of-pocket costs can add up fast. Patients could have to pay more than $950 dollars a month for Ozempic and more than $1,300 dollars for Wegovy.

While these same drugs are a fraction of the price in overseas. For example, lawmakers say the price for Ozempic is $155 in Canada and $59 in Germany.

“The vast majority of the American people are sick and tired of paying outrageously high prices for prescription drugs,” said Sen. Bernie Sanders, (I) Vermont.

Lawmakers say the drug company has made $50 billion on the sales of those two drugs since 2018. Tuesday, members of the U.S. Senate Committee on Health, Education, Labor & Pensions (HELP) pressed the drug company’s CEO, Lars Jørgensen for answers.

“We don’t decide the price for patients, that’s set by the insurance company,” said Lars Fruergaard Jørgensen, President and CEO of Novo Nordisk.

…